Hetero Drugs will establish its Latin American operations center in Colombia
Hetero Drugs instalará su centro de operaciones latinoamericano en Colombia
Intel ID : 222572
| Synopsis |
|
Pharmaceutical group Hetero Drugs announced it will establish its Latin American operations center in Colombia, investing some USD 20m throughout the next three years. According to Hetero Drugs' president Bandi Reddy, the Colombian pharmaceutical sector is attractive to invest, since it represents some USD 3.70bn, with a positive growth estimate.
(content in spanish)
El grupo farmacéutico indio Hetero Drugs ha anunciado que instalará su centro de operaciones y distribución para Latinoamérica en Colombia, en el que tiene previsto invertir USD 20m durante los próximos tres años. Según el presidente de la compañía, Bandi Reddy, el sector colombiano de los medicamentos supone un gran atractivo de inversión puesto que representa unos USD 3.700m, con una previsión positiva de crecimiento. |
| Intel ID | 222572 | |
| Value | ND | |
| Native Currency |
US Dollar (USD)
Exchange Rate:  |
|
| Date |
|
|
| Country |  |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.